Literature DB >> 1376294

Ovarian germ cell malignancies: the Yale University experience.

P E Schwartz, S K Chambers, J T Chambers, E Kohorn, S McIntosh.   

Abstract

Mesh：

Substances：

Year:  1992        PMID： 1376294     DOI： 10.1016/0090-8258(92)90486-3

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN： 0090-8258            Impact factor:   5.482


× No keyword cloud information.
  3 in total

Review 1.  Chemotherapy for malignant germ cell ovarian cancer in adult patients with early stage, advanced and recurrent disease.

Authors:  Albiruni Ryan Abdul Razak; Louise Li; Andrew Bryant; Ivan Diaz-Padilla
Journal:  Cochrane Database Syst Rev       Date:  2011-03-16

2.  Ovarian dysgerminoma in two sisters.

Authors:  Bander F Aldhafery
Journal:  J Family Community Med       Date:  2008-09

3.  "Chronic fatigue, quality of life and long-term side-effects of chemotherapy in patients treated for non-epithelial ovarian cancer: national case-control protocol study of the GINECO-Vivrovaire rare tumors INCa French network for rare malignant ovarian tumors".

Authors:  François Gernier; Djihane Ahmed-Lecheheb; Patricia Pautier; Anne Floquet; Cédric Nadeau; Sophie Frank; Jérôme Alexandre; Frédéric Selle; Dominique Berton-Rigaud; Elsa Kalbacher; Hubert Orfeuvre; Alain Lortholary; Paule Augereau; Fabien Labombarda; Lionel Perrier; Jean-Michel Grellard; Idlir Licaj; Bénédicte Clarisse; Aude-Marie Savoye; Héloise Bourien; Thibaut De La Motte Rouge; Jean-Emmanuel Kurtz; Katia Kerdja; Anaïs Lelaidier; Amandine Charreton; Isabelle Ray-Coquard; Florence Joly
Journal:  BMC Cancer       Date:  2021-10-26       Impact factor: 4.430
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.